Raloxifene attenuates Pseudomonas aeruginosa pyocyanin production and virulence.

[1]  Frederick M Ausubel,et al.  Correction for Liberati et al., An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants , 2006, Proceedings of the National Academy of Sciences.

[2]  T. Tolker-Nielsen,et al.  Computer-Aided Identification of Recognized Drugs as Pseudomonas aeruginosa Quorum-Sensing Inhibitors , 2009, Antimicrobial Agents and Chemotherapy.

[3]  Frederick M. Ausubel,et al.  Molecular Mechanisms of Bacterial Virulence Elucidated Using a Pseudomonas Aeruginosa– Caenorhabditis Elegans Pathogenesis Model , 2022 .

[4]  R. Tompkins,et al.  Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2-heptylquinoline in cell-to-cell communication. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Jason A. Papin,et al.  * Corresponding authors , 2006 .

[6]  The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections. , 2009, FEMS microbiology letters.

[7]  Hege S. Beard,et al.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.

[8]  F. Ausubel,et al.  Caenorhabditis elegans as a host for the study of host-pathogen interactions. , 2002, Current opinion in microbiology.

[9]  Eric Haugen,et al.  Comprehensive transposon mutant library of Pseudomonas aeruginosa , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Shawn Lewenza,et al.  Construction of a mini-Tn5-luxCDABE mutant library in Pseudomonas aeruginosa PAO1: a tool for identifying differentially regulated genes. , 2005, Genome research.

[11]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[12]  D. Hassett,et al.  Pseudomonas aeruginosa exotoxin pyocyanin causes cystic fibrosis airway pathogenesis. , 2009, The American journal of pathology.

[13]  Fiona S. L. Brinkman,et al.  The Association of Virulence Factors with Genomic Islands , 2009, PloS one.

[14]  Lei Xie,et al.  Detecting evolutionary relationships across existing fold space, using sequence order-independent profile–profile alignments , 2008, Proceedings of the National Academy of Sciences.

[15]  L. Thomashow,et al.  Functional Analysis of Genes for Biosynthesis of Pyocyanin and Phenazine-1-Carboxamide from Pseudomonas aeruginosa PAO1 , 2001, Journal of bacteriology.

[16]  Philip E. Bourne,et al.  Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi-Drug and Extensively Drug Resistant Tuberculosis , 2009, PLoS Comput. Biol..

[17]  Anne E Carpenter,et al.  High-throughput screen for novel antimicrobials using a whole animal infection model. , 2009, ACS chemical biology.

[18]  Li Li,et al.  Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial , 2006, Genome Biology.

[19]  S. Lory,et al.  Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen , 2000, Nature.

[20]  A. Clatworthy,et al.  Targeting virulence: a new paradigm for antimicrobial therapy , 2007, Nature Chemical Biology.

[21]  D. Hassett,et al.  Pseudomonas aeruginosa Pyocyanin Is Critical for Lung Infection in Mice , 2004, Infection and Immunity.

[22]  Philip E. Bourne,et al.  A robust and efficient algorithm for the shape description of protein structures and its application in predicting ligand binding sites , 2007, BMC Bioinformatics.

[23]  N. Munakata.  [Genetics of Caenorhabditis elegans]. , 1989, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[24]  M. Kollef,et al.  The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections , 2012, Drugs.

[25]  F. Ausubel,et al.  Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. Hassett,et al.  The role of pyocyanin in Pseudomonas aeruginosa infection. , 2004, Trends in molecular medicine.

[27]  H. Chao,et al.  Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women. , 2008, Maturitas.

[28]  T. Pitt,et al.  Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain , 2007, BMC Microbiology.

[29]  Sarah L. Kinnings,et al.  Novel computational approaches to polypharmacology as a means to define responses to individual drugs. , 2012, Annual review of pharmacology and toxicology.

[30]  I. Crawford,et al.  Identification and characterization of genes for a second anthranilate synthase in Pseudomonas aeruginosa: interchangeability of the two anthranilate synthases and evolutionary implications , 1990, Journal of bacteriology.

[31]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.